FB2026_03 , released September 17, 2026
Human Disease Model Report: peroxisome biogenesis disorder 10A
Open Close
General Information
Name
peroxisome biogenesis disorder 10A
FlyBase ID
FBhh0000053
Overview

This report describes peroxisome biogenesis disorder 10A (PBD10A), which is a subtype of peroxisome biogenesis disorder; PBD10A exhibits autosomal recessive inheritance. The human gene implicated in this disease is PEX3, which encodes a protein that is essential for the assembly of functional peroxisomes. There is a single high-scoring fly ortholog, Pex3, for which RNAi targeting constructs and alleles caused by insertional mutagenesis have been generated.

A transgenic construct carrying a cDNA of Hsap\PEX3 has been introduced into flies. Heterologous rescue (functional complementation) of the peroxisome loss phenotype of Dmel\Pex3 null mutants has been demonstrated.

Amorphic mutations of Dmel\Pex3 are lethal in the larval stage. For loss-of-function mutations, observed phenotypes include aspects similar to the human disease, including reduced body size, reduced lifespan, elevated very long chain fatty acid (VLCFA) levels, and a failure to assemble functional peroxisomes.

[updated Apr. 2017 by FlyBase; FBrf0222196]

Disease Summary Information
Parent Disease Summary: peroxisome biogenesis disorder
Symptoms and phenotype

Newborns affected with Zellweger syndrome (ZS) are hypotonic, feed poorly, and have distinctive facies, seizures, and liver cysts with hepatic dysfunction. Bony stippling of the patella(e) and other long bones may occur. The neurological defects include demyelination, retinal dystrophy, hearing loss and seizures. Infants with ZS are significantly impaired and typically die during the first year of life, usually having made no developmental progress. Older children have retinal dystrophy, sensorineural hearing loss, developmental delay with hypotonia, and liver dysfunction. The clinical courses of the milder forms of peroxisome biogenesis disorder, neonatal adrenoleukodystrophy (NALD) and infantile Refsum disease (IRD), are variable and may include developmental delays, hearing loss, vision impairment, liver dysfunction, episodes of hemorrhage, and intracranial bleeding. While some children can be very hypotonic, others learn to walk and talk. The condition is often slowly progressive [from GeneReviews, Peroxisome Biogenesis Disorders, Zellweger Syndrome Spectrum, 2015.09.09].

PBD syndrome is characterized clinically by severe neurologic dysfunction, craniofacial abnormalities, and liver dysfunction. There are 4 main phenotypic classes of PBDs that were defined prior to the molecular characterization; three of them in order of severity, Zellweger syndrome, neonatal adrenoleukodystrophy (NALD), and infantile Refsum disease (IRD), form a spectrum of overlapping features. The most severely affected patients with classic Zellweger syndrome die within the first year. Zellweger syndrome is indicated by the "A" in the OMIM subtype designation; the less severe forms are indicated with a "B" in the OMIM subtype designation (BSC). The fourth class, rhizomelic chondrodysplasia punctata (RCDP1), displays a distinct PBD phenotype. [from MIM:214100; 15.08.10]

Specific Disease Summary: peroxisome biogenesis disorder 10A
OMIM report

[PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A](https://omim.org/entry/614882)

Human gene(s) implicated

[PEROXISOME BIOGENESIS FACTOR 3; PEX3](https://omim.org/entry/603164)

Symptoms and phenotype

Mutations in Hsap\PEX3 are associated exclusively with the most severe phenotype in the peroxisome biogenesis disorder spectrum (Zellwegers syndrome). [from Gene_reviews: Peroxisome Biogenesis Disorders, Zellweger Syndrome Spectrum, 2015.08.10]

PBD10A is one of a group of peroxisome biogenesis disorders that presents in infants with severe seizures, profound hypotonia, and inability to feed; additional characteristics are craniofacial and eye abnormalities, neuronal migration defects, enlarged liver, small size, and bone abnormalities. Affected individuals do not show significant development and usually die in the first year. [from MIM:614882; 15.08.10]

Genetics

PBD10A is autosomal recessive and is caused by mutations in the Hsap\PEX3 gene. [from MIM:614882; 15.08.10]

Cellular phenotype and pathology

Peroxisomal membrane formation is completely absent in cell lines from individuals with mutations in HSap\PEX3 (peroxisome biogenesis disorder 10A). [from Gene_reviews: Peroxisome Biogenesis Disorders, Zellweger Syndrome Spectrum, 2015.08.10]

Molecular information

Hsap\PEX3 is involved in peroxisome biosynthesis and integrity. It assembles membrane vesicles before the matrix proteins are translocated. [from Gene_reviews: Peroxisome Biogenesis Disorders, Zellweger Syndrome Spectrum; Gene_cards:PEX3, 2015.08.10]

PBD10A is is one of a group of peroxisome biogenesis disorders resulting from disordered peroxisome biogenesis. [from MIM:614882; 15.08.10]

External links
Disease synonyms
PBD10A
Zellweger syndrome
Ortholog Information
Human gene(s) in FlyBase
Human gene (HGNC)
D. melanogaster ortholog (based on DIOPT)
Comments on ortholog(s)

One to one: 1 human to 1 Drosophila.

Other mammalian ortholog(s) used
    D. melanogaster Gene Information (1)
    Gene Snapshot
    Peroxin 3 (Pex3) encodes a peroxisomal membrane protein (PMP) involved in de novo peroxisome biogenesis from the endoplasmic reticulum and PMP import from the cytosol. It also facilitates the insertion of proteins into the membrane of mature peroxisomes via its interaction with the PMP chaperone encoded by Pex19. [Date last reviewed: 2019-03-14]
    Gene Groups / Pathways
    Comments on ortholog(s)

    Ortholog of human gene PEX3 (1 Drosophila to 1 human). Dmel\Pex3 shares 34% identity and 52% similarity with human PEX3.

    Orthologs and Alignments from DRSC
    DIOPT - DRSC Integrative Ortholog Prediction Tool - Click the link below to search for orthologs in Humans
    Other Genes Used: Viral, Bacterial, Synthetic (0)
      Summary of Physical Interactions (1 groups)
      protein-protein
      Interacting group
      Assay
      References
      Alleles Reported to Model Human Disease (Disease Ontology) (5 alleles)
      Models Based on Experimental Evidence ( 3 )
      Modifiers Based on Experimental Evidence ( 2 )
      Allele
      Disease
      Interaction
      References
      Models Based on Experimental Evidence ( 0 )
      Allele
      Disease
      Evidence
      References
      Modifiers Based on Experimental Evidence ( 1 )
      Allele
      Disease
      Interaction
      References
      Alleles Representing Disease-Implicated Variants
      Genetic Tools, Stocks and Reagents
      Sources of Stocks
      Contact lab of origin for a reagent not available from a public stock center.
      Bloomington Stock Center Disease Page
      Related mammalian, viral, bacterial, or synthetic transgenes
      Allele
      Transgene
      Publicly Available Stocks
      Selected Drosophila transgenes
      Allele
      Transgene
      Publicly Available Stocks
      RNAi constructs available
      Allele
      Transgene
      Publicly Available Stocks
      Selected Drosophila classical alleles
      Allele
      Allele class
      Mutagen
      Publicly Available Stocks
      P-element activity
      amorphic allele - molecular evidence
      Delta2-3 transposase
      References (8)